BeOne's Brukinsa cuts lymphoma progression risk by 43% in trial

June 30, 2026 6:00 AM

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235) announced positive topline results from its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found